Risk Literacy Among Portuguese Medical and Dentistry Students (RiskommPt)

February 16, 2021 updated by: Niklas Keller, Harding Center for Risk Literacy

Risk Literacy Among Portuguese Medical and Dentistry Students - a Cohort Study

This study is an online survey to assess risk literacy among students of the medical and dentistry faculties in Portugal. Risk literacy is the capability to understand and interpret statistical information, based on simple rules of thumb.

The investigators assess the level of "medical risk literacy" among Portuguese medical and dentistry students with the Quick Risk Test (QRT) and the multiple choice version of the Berlin Numeracy Test (BNT).

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

This study is an online survey to assess risk literacy among students of the medical and dentistry faculties in Portugal.

The primary outcome is the measurement of "medical risk literacy" among Portuguese medical and dentistry students as assessed with the Quick Risk Test (QRT) and the multiple choice version of the Berlin Numeracy Test (BNT).

Secondary outcomes is to investigate whether study year, faculty, and prior statistical education have an impact on the level of risk literacy. Participants will be invited via email through established faculty mailing lists or established social media channels. For the survey, an online-survey tool (Unipark, academic program or Questback) will be used. Participation is voluntary and can be withdrawn at any time by aborting the survey (e.g. via closing the browser). Informed consent will be acquired at the beginning of the survey. English and Portuguese versions will be available to the participant.

As incentive to participate, participants completing the brief (ca.15 minutes) online-questionnaire will be granted a free subscriptions to the AMBOSS medical learning platform (2 weeks) and have the option to be entered into a lottery with the possibility of winning one of 3 free 6 month subscriptions.

After completion of the questionnaire, participants will be re-directed to a dedicated AMBOSS website where they can enter their email-address to take part in the lottery. This assures strict separation of the anonymous experimental data and the AMBOSS subscription data. Prior to initiation of the questionnaire, in the invitation email, participants will be provided the full participant information and made aware that, due to anonymity, it will not be possible to retrospectively delete their responses once the survey has been completed.

As the primary outcome is a baseline assessment and the secondary outcomes are exploratory analyses, no hypotheses will be tested in this survey.

Study Type

Observational

Enrollment (Actual)

950

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Germany
    • Brandenburg
      • Potsdam, Brandenburg, Germany, 14482
        • Harding Center for Risk Literacy

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

All matriculated students at Portuguese medical and dental faculties will be invited to participate (participation of faculties to be confirmed).

Description

Inclusion Criteria:

  • medical and dentistry students of Portuguese faculties
  • active matriculation at a Portuguese faculty
  • completion of the questionnaire

Exclusion Criteria:

  • no active matriculation at a Portuguese faculty

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Cross section of the student body.
Matriculated students at Portuguese medical and dental faculties.
Other: No Intervention. Observational study.
No Intervention. Observational study.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Quantitative measurement of "medical risk literacy"
Time Frame: 1st - 30st of May 2020
Quantitative measurement of "medical risk literacy" among Portuguese medical and dentistry students measured with the Quick Risk Test (QRT) [Jenny, Keller & Gigerenzer, 2018] and the multiple choice version of the Berlin Numeracy Test (BNT) [Cokely & Galesic, 2012].
1st - 30st of May 2020

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Impact of study year, faculty, and prior statistical education on the level of risk literacy
Time Frame: 1st - 30st of May 2020
Secondary outcomes is to investigate, whether study year, faculty, and prior statistical education have an impact on the level of risk literacy.
1st - 30st of May 2020

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Harding Center for Risk Literacy

Investigators

  • Principal Investigator: Niklas Keller, Dr. rer. nat, Harding Center, Charité Universitätsmedizin Berlin, Germany
  • Principal Investigator: Alexej Zhogov, Harding Center for Risk Literacy, Charité Universitätsmedizin Berlin, Germany
  • Principal Investigator: Maxim Benz, Harding Center for Risk Literacy, Charité Universitätsmedizin Berlin, Germany
  • Principal Investigator: Mário Pereira Pinto, Dr., Presidency of the Portuguese Republic, Portugal
  • Principal Investigator: Henrique Proença da Cunha, Dr., Faculty of Medicine of the University of Coimbra, Portugal
  • Principal Investigator: Gerd Gigerenzer, Prof., Harding Center for Risk Literacy
  • Principal Investigator: Miriam Jenny, Dr., Harding Center for Risk Literacy

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Helpful Links

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 15, 2020

Primary Completion (Actual)

July 31, 2020

Study Completion (Actual)

July 31, 2020

Study Registration Dates

First Submitted

May 4, 2020

First Submitted That Met QC Criteria

May 5, 2020

First Posted (Actual)

May 8, 2020

Study Record Updates

Last Update Posted (Actual)

February 17, 2021

Last Update Submitted That Met QC Criteria

February 16, 2021

Last Verified

February 1, 2021

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • HC2019/11

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

We plan to share our anonymized raw data.

IPD Sharing Time Frame

After the completion of the study.

IPD Sharing Access Criteria

undecided. Further research in risk literacy. For example other countries, or time delay. Or intervention studies.

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • SAP
  • ICF
  • CSR

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Medical Education

Clinical Trials on No Intervention. Observational study.

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Dominican Republic

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe